Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Sell
22
RAFLF Quote, Financials, Valuation and Earnings
Last price:
$0.67
Seasonality move
:
10.18%
Day range:
$0.67 - $0.67
52-week range:
$0.65 - $0.77
Dividend yield:
2.66%
P/E ratio:
27.83x
P/S ratio:
2.41x
P/B ratio:
1.65x
Volume:
--
Avg. volume:
67
1-year change:
-13.58%
Market cap:
$1.2B
Revenue:
$526.3M
EPS (TTM):
$0.02
Analysts' Opinion
-
Consensus RatingRaffles Medical Group has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Raffles Medical Group has an estimated downside of -- from its current price of $0.67.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $0.67.
Fair Value
-
According to the consensus of 0 analysts, Raffles Medical Group has -- downside to fair value with a price target of -- per share.
RAFLF vs. S&P 500
-
Over the past 5 trading days, Raffles Medical Group has underperformed the S&P 500 by -1.77% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Raffles Medical Group does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Raffles Medical Group has grown year-over-year revenues for 9 quarters straight. In the most recent quarter Raffles Medical Group reported revenues of --.
Earnings Growth
-
Raffles Medical Group earnings have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Raffles Medical Group reported earnings per share of --.
Enterprise value:
1.1B
EV / Invested capital:
--
Price / LTM sales:
2.41x
EV / EBIT:
15.88x
EV / Revenue:
2.06x
PEG ratio (5yr expected):
2.73x
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
11.10x
Gross Profit (TTM):
$334M
Return On Assets:
3.98%
Net Income Margin (TTM):
8.68%
Return On Equity:
5.89%
Return On Invested Capital:
5.51%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2018-12-31 | 2019-12-31 | |
| Income Statement | ||||||
| Revenue | $346.1M | $362.5M | $382.6M | $92.8M | $100M | |
| Gross Profit | -- | -- | -- | $73.1M | $79.9M | |
| Operating Income | -- | -- | -- | $19.2M | $17.7M | |
| EBITDA | -- | -- | -- | $22.4M | $24.2M | |
| Diluted EPS | -- | -- | -- | $0.01 | $0.01 | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $193M | $266.4M | $310.4M | $371.5M | $350.8M | |
| Total Assets | $949.9M | $1.1B | $1.1B | $1.1B | $1.1B | |
| Current Liabilities | $175.6M | $236.5M | $290.2M | $305.8M | $292.7M | |
| Total Liabilities | $319M | $393M | $399.9M | $374.7M | $358.7M | |
| Total Equity | $630.9M | $688.3M | $690.5M | $748.2M | $759.9M | |
| Total Debt | $120.9M | $135.5M | $110.8M | $52.2M | $51.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2018-12-31 | 2019-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $60M | $69.3M | $81.5M | $14.8M | $27.6M | |
| Cash From Investing | -- | -- | -- | -$26.4M | -$25.9M | |
| Cash From Financing | -- | -- | -- | $14.3M | $23.4M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
RAFLF
Sector
Market Cap
$1.2B
$46.5M
Price % of 52-Week High
86.42%
47.23%
Dividend Yield
2.66%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
-13.58%
-31.38%
Beta (5-Year)
0.095
0.772
Dividend yield:
2.66%
Annualized payout:
$0.03
Payout ratio:
--
Growth streak:
2 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$0.67
200-day SMA
Sell
Level
$0.70
Bollinger Bands (100)
Sell
Level
0.65 - 0.69
Chaikin Money Flow
Buy
Level
81.7K
20-day SMA
Sell
Level
$0.67
Relative Strength Index (RSI14)
Sell
Level
45.69
ADX Line
Neutral
Level
Williams %R
Neutral
Level
-23.3051
50-day SMA
Sell
Level
$0.67
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
240.2K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.6919)
Buy
CA Score
(Annual)
Level (0.8463)
Buy
Beneish M-Score
(Annual)
Level (-3.3499)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-0.9679)
Buy
Piotroski F Score
(Annual)
Level (5)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The Hospital services segment provides medical services and operates hospitals, medical laboratories, and imaging centers. The Healthcare Services segment operates medical clinics and other general medical services, provides health insurance, trades pharmaceutical and nutraceutical products and diagnostic equipment, and provides management and consultancy services. The Investment holding segment involves investment in properties.
Stock Forecast FAQ
In the current month, RAFLF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RAFLF average analyst price target in the past 3 months is --.
-
Where Will Raffles Medical Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that Raffles Medical Group share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Raffles Medical Group?
Analysts are divided on their view about Raffles Medical Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Raffles Medical Group is a Sell and believe this share price will rise from its current level to --.
-
What Is Raffles Medical Group's Price Target?
The price target for Raffles Medical Group over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is RAFLF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Raffles Medical Group is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of RAFLF?
You can purchase shares of Raffles Medical Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Raffles Medical Group shares.
-
What Is The Raffles Medical Group Share Price Today?
Raffles Medical Group was last trading at $0.67 per share. This represents the most recent stock quote for Raffles Medical Group. Yesterday, Raffles Medical Group closed at $0.67 per share.
-
How To Buy Raffles Medical Group Stock Online?
In order to purchase Raffles Medical Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
66
ARQQ alert for Dec 28
Arqit Quantum [ARQQ] is down 3.22% over the past day.
Buy
64
QMCO alert for Dec 28
Quantum [QMCO] is up 4.72% over the past day.
Buy
62
ALGS alert for Dec 28
Aligos Therapeutics [ALGS] is down 4.82% over the past day.
